2023
230. Oral Health of Rural Cameroonian Children: A Pilot Study in Bamendou.
Aimond G, Thivichon-prince B, Bernard-granger C, Gisle C, Caron T, Jiokeng Av, Majoli S, Maurin Jc, Ducret M, Laforest L
(2023) Children (basel) 10 :
229. Assessment of guide fitting using an intra-oral scanner: An in vitro study.
Bittar E, Binvignat P, Villat C, Maurin Jc, Ducret M, Richert R
(2023) J Dent 135 :104590-104590
228. Recent Developments in Layer-by-Layer Assembly for Drug Delivery and Tissue Engineering Applications.
Borges J, Zeng J, Liu Xq, Chang H, Monge C, Garot C, Ren Kf, Machillot P, Vrana Ne, Lavalle P, Akagi T, Matsusaki M, Ji J, Akashi M, Mano Jf, Gribova V, Picart C
(2023) Adv Healthc Mater :e2302713-e2302713
227. In vivo intranasal delivery of coagulation factor IX: a proof-of-concept study.
Fieux M, Rovera R, Coiffier C, Colomb E, Enjolras N, Béquignon E, Monge C, Le Quellec S
(2023) J Thromb Haemost :
226. Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus.
Lamrayah M, Charriaud F, Desmares M, Coiffier C, Megy S, Colomb E, Terreux R, Lucifora J, Durantel D, Verrier B
(2023) Antiviral Res 209 :105483-105483
225. Poloxamers Have Vaccine-Adjuvant Properties by Increasing Dissemination of Particulate Antigen at Distant Lymph Nodes.
Lamrayah M, Phelip C, Rovera R, Coiffier C, Lazhar N, Bartolomei F, Colomb E, Verrier B, Monge C, Richard S
(2023) Molecules 28 :
224. Analysis of the P. lividus sea urchin genome highlights contrasting trends of genomic and regulatory evolution in deuterostomes.
Marlétaz F, Couloux A, Poulain J, Labadie K, Da Silva C, Mangenot S, Noel B, Poustka Aj, Dru P, Pegueroles C, Borra M, Lowe Ek, Lhomond G, Besnardeau L, Le Gras S, Ye T, Gavriouchkina D, Russo R, Costa C, Zito F, Anello L, Nicosia A, Ragusa Ma, Pascual M, Molina Md, Chessel A, Di Carlo M, Turon X, Copley Rr, Exposito Jy, Martinez P, Cavalieri V, Ben Tabou De Leon S, Croce J, Oliveri P, Matranga V, Di Bernardo M, Morales J, Cormier P, Geneviève Am, Aury Jm, Barbe V, Wincker P, Arnone Mi, Gache C, Lepage T
(2023) Cell Genom 3 :100295-100295
223. Skin Cell and Tissue Responses to Cross-Linked Hyaluronic Acid in Low-Grade Inflammatory Conditions.
Sanchez B, Ferraro S, Josset-lamaugarny A, Pagnon A, Hee Ck, Nakab L, Sigaudo-roussel D, Fromy B
(2023) Int J Inflam 2023 :3001080-3001080
222. DLin-MC3-Containing mRNA Lipid Nanoparticles Induce an Antibody Th2-Biased Immune Response Polarization in a Delivery Route-Dependent Manner in Mice.
Yavuz A, Coiffier C, Garapon C, Gurcan S, Monge C, Exposito Jy, Arruda Dc, Verrier B
(2023) Pharmaceutics 15 :
2022
221. Comparison of Physicochemical Properties of LipoParticles as mRNA Carrier Prepared by Automated Microfluidic System and Bulk Method.
Ayad C, Yavuz A, Salvi Jp, Libeau P, Exposito Jy, Ginet V, Monge C, Verrier B, Arruda Dc
(2022) Pharmaceutics 14 :
220. Physiological Impact of a Synthetic Elastic Protein in Arterial Diseases Related to Alterations of Elastic Fibers: Effect on the Aorta of Elastin-Haploinsufficient Male and Female Mice.
Boëté Q, Lo M, Liu Kl, Vial G, Lemarié E, Rougelot M, Steuckardt I, Harki O, Couturier A, Gaucher J, Bouyon S, Demory A, Boutin-paradis A, El Kholti N, Berthier A, Pépin Jl, Briançon-marjollet A, Lambert E, Debret R, Faury G
(2022) Int J Mol Sci 23 :
219. Aqueous suspensions of Fuller's earth potentiate the adsorption capacities of paraoxon and improve skin decontamination properties.
Danoy A, Durmaz K, Paoletti M, Vachez L, Roul A, Sohier J, Verrier B
(2022) J Hazard Mater 425 :127714-127714
218. Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes.
Desmares M, Delphin M, Chardès B, Pons C, Riedinger J, Michelet M, Rivoire M, Verrier B, Salvetti A, Lucifora J, Durantel D
(2022) Antiviral Res 206 :105386-105386
217. Mucosal Adjuvants Delivered by a Mucoadhesive Patch for Sublingual Administration of Subunit Vaccines.
Monge C, Ayad C, Paris Al, Rovera R, Colomb E, Verrier B
(2022) Int J Mol Sci 23 :
216. Gas1 Regulates Patterning of the Murine and Human Dentitions through Sonic Hedgehog.
Seppala M, Thivichon-prince B, Xavier Gm, Shaffie N, Sangani I, Birjandi Aa, Rooney J, Lau Jns, Dhaliwal R, Rossi O, Riaz Ma, Stonehouse-smith D, Wang Y, Papageorgiou Sn, Viriot L, Cobourne Mt
(2022) J Dent Res 101 :473-482
215. Plicidentine in the oral fangs of parrotfish (Scarinae, Labriformes).
Viviani J, Leblanc A, Rurua V, Mou T, Liao V, Lecchini D, Galzin R, Viriot L
(2022) J Anat 241 :601-615
214. Design and Evaluation of Autophagy-Inducing Particles for the Treatment of Abnormal Lipid Accumulation.
Zagkou S, Marais V, Zeghoudi N, Guillou El, Eskelinen El, Panasyuk G, Verrier B, Primard C
(2022) Pharmaceutics 14 :
2021
213. Latent TGF-β Activation Is a Hallmark of the Tenascin Family.
Aubert A, Mercier-gouy P, Aguero S, Berthier L, Liot S, Prigent L, Alcaraz Lb, Verrier B, Terreux R, Moali C, Lambert E, Valcourt U
(2021) Front Immunol 12 :613438-613438
212. LipoParticles: Lipid-Coated PLA Nanoparticles Enhanced In Vitro mRNA Transfection Compared to Liposomes.
Ayad C, Libeau P, Lacroix-gimon C, Ladavière C, Verrier B
(2021) Pharmaceutics 13 :
211. Gene expression patterns associated with dental replacement in the rabbit, a new model for the mammalian dental replacement mechanisms.
Bertonnier-brouty L, Viriot L, Joly T, Charles C
(2021) Dev Dyn 250 :1494-1504
210. Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms.
Da Costa D, Exbrayat-héritier C, Rambaud B, Megy S, Terreux R, Verrier B, Primard C
(2021) J Nanobiotechnology 19 :12-12
209. Glycation by glyoxal leads to profound changes in the behavior of dermal fibroblasts.
Guillon C, Ferraro S, Clément S, Bouschbacher M, Sigaudo-roussel D, Bonod C
(2021) Bmj Open Diabetes Res Care 9 :
208. Seaweed Sulfated Polysaccharides against Respiratory Viral Infections.
Jabeen M, Dutot M, Fagon R, Verrier B, Monge C
(2021) Pharmaceutics 13 :
207. Combining an optimized mRNA template with a double purification process allows strong expression of in vitro transcribed mRNA.
Linares-fernández S, Moreno J, Lambert E, Mercier-gouy P, Vachez L, Verrier B, Exposito Jy
(2021) Mol Ther Nucleic Acids 26 :945-956
206. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins.
Liot S, Balas J, Aubert A, Prigent L, Mercier-gouy P, Verrier B, Bertolino P, Hennino A, Valcourt U, Lambert E
(2021) Front Immunol 12 :612271-612271
205. Development of thymic tumor in [LSL:KrasG12D; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis.
Liot S, El Kholti N, Balas J, Genestier L, Verrier B, Valcourt U, Lambert E
(2021) Sci Rep 11 :15075-15075
204. Sublingual antigen delivery: a solution for needle-free HIV vaccination.
Monge C, Verrier B
(2021) Expert Rev Vaccines 20 :1047-1050
203. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.
Pacheco Y, Valeyre D, El Jammal T, Vallee M, Chevalier F, Lamartine J, Sigaudo-roussel D, Verrier B, Israel-biet D, Freymond N, Cottin V, Calender A
(2021) Cells 10 :
202. Sublingual protein delivery by a mucoadhesive patch made of natural polymers.
Paris Al, Caridade S, Colomb E, Bellina M, Boucard E, Verrier B, Monge C
(2021) Acta Biomater 128 :222-235
201. Sublingual vaccination and delivery systems.
Paris Al, Colomb E, Verrier B, Anjuère F, Monge C
(2021) J Control Release 332 :553-562
200. Biodistribution of surfactant-free poly(lactic-acid) nanoparticles and uptake by endothelial cells and phagocytes in zebrafish: Evidence for endothelium to macrophage transfer.
Rességuier J, Levraud Jp, Dal Nk, Fenaroli F, Primard C, Wohlmann J, Carron G, Griffiths Gw, Le Guellec D, Verrier B
(2021) J Control Release 331 :228-245
2020
199. Development of an antibacterial nanocomposite hydrogel for human dental pulp engineering.
Bekhouche M, Bolon M, Charriaud F, Lamrayah M, Da Costa D, Primard C, Costantini A, Pasdeloup M, Gobert S, Mallein-gerin F, Verrier B, Ducret M, Farges Jc
(2020) J Mater Chem B 8 :8422-8432
198. Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker.
Liot S, Aubert A, Hervieu V, Kholti Ne, Schalkwijk J, Verrier B, Valcourt U, Lambert E
(2020) Matrix Biol Plus 6-7 :100021-100021
197. Molecular Dynamics Studies of Poly(Lactic Acid) Nanoparticles and Their Interactions with Vitamin E and TLR Agonists Pam1CSK4 and Pam3CSK4.
Megy S, Aguero S, Da Costa D, Lamrayah M, Berthet M, Primard C, Verrier B, Terreux R
(2020) Nanomaterials (basel) 10 :
2019
196. Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation.
Coolen Al, Lacroix C, Mercier-gouy P, Delaune E, Monge C, Exposito Jy, Verrier B
(2019) Biomaterials 195 :23-37
195. Molecular modelling of TLR agonist Pam(3)CSK(4) entrapment in PLA nanoparticles as a tool to explain loading efficiency and functionality.
Lamrayah M, Charriaud F, Hu S, Megy S, Terreux R, Verrier B
(2019) Int J Pharm 568 :118569-118569
194. Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response.
Linares-fernandez S, Lacroix C, Exposito Jy, Verrier B
(2019) Trends Mol Med :
2017
193. Tuning the Hydrophilic/Hydrophobic Balance to Control the Structure of Chitosan Films and Their Protein Release Behavior.
Becerra J, Sudre G, Royaud I, Montserret R, Verrier B, Rochas C, Delair T, David L
(2017) Aaps Pharmscitech 18 :1070-1083
192. Nanoparticle-Based Dressing: The Future of Wound Treatment?
Berthet M, Gauthier Y, Lacroix C, Verrier B, Monge C
(2017) Trends Biotechnol 35 :770-784
191. Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles.
Boisgard As, Lamrayah M, Dzikowski M, Salmon D, Kirilov P, Primard C, Pirot F, Fromy B, Verrier B
(2017) Eur J Pharm Biopharm 116 :51-60
190. Antibiotic incorporation in jet-sprayed nanofibrillar biodegradable scaffolds for wound healing.
Dzikowski M, Castanie N, Guedon A, Verrier B, Primard C, Sohier J
(2017) Int J Pharm :
189. Neutralizing and Targeting Properties of a New Set of α4β7-Specific Antibodies Are Influenced by Their Isotype.
Girard A, Jelicic K, Van Ryk D, Rochereau N, Cicala C, Arthos J, Noailly B, Genin C, Verrier B, Laurant S, Razanajaoana-doll D, Pin Jj, Paul S
(2017) J Acquir Immune Defic Syndr 75 :118-127
188. Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses.
Gutjahr A, Papagno L, Nicoli F, Lamoureux A, Vernejoul F, Lioux T, Gostick E, Price Da, Tiraby G, Perouzel E, Appay V, Verrier B, Paul S
(2017) J Immunol 198 :4205-4209
187. Improving bioassay sensitivity through immobilization of bio-probes onto reactive micelles.
Jimenez-sanchez G, Terrat C, Verrier B, Gigmes D, Trimaille T
(2017) Chem Commun (camb) 53 :8062-8065
186. Critical role for skin-derived migratory DCs and Langerhans cells in TFH and GC responses after intradermal immunization.
Levin C, Bonduelle O, Nuttens C, Primard C, Verrier B, Boissonnas A, Combadiere B
(2017) J Invest Dermatol 0 :0
185. Quiescence of human muscle stem cells is favored by culture on natural biopolymeric films.
Monge C, Distasio N, Rossi T, Sebastien M, Sakai H, Kalman B, Boudou T, Tajbakhsh S, Marty I, Bigot A, Mouly V, Picart C
(2017) Stem Cell Res Ther 8 :104-104
184. Specific and Efficient Uptake of Surfactant-Free Poly(Lactic Acid) Nanovaccine Vehicles by Mucosal Dendritic Cells in Adult Zebrafish after Bath Immersion.
Resseguier J, Delaune E, Coolen Al, Levraud Jp, Boudinot P, Le Guellec D, Verrier B
(2017) Front Immunol 8 :190-190
183. Comparison of four different fuller's earth formulations in skin decontamination.
Roul A, Le Ca, Gustin Mp, Clavaud E, Verrier B, Pirot F, Falson F
(2017) J Appl Toxicol :
182. Exploiting Natural Cross-reactivity between Human Immunodeficiency Virus (HIV)-1 p17 Protein and Anti-gp41 2F5 Antibody to Induce HIV-1 Neutralizing Responses In Vivo.
Verrier B, Paul S, Terrat C, Bastide L, Ensinas A, Phelip C, Chanut B, Bulens-grassigny L, Jospin F, Guillon C
(2017) Front Immunol 8 :770-770
181. Ternary polysaccharide complexes: Colloidal drug delivery systems stabilized in physiological media.
Wu D, Ensinas A, Verrier B, Cuvillier A, Champier G, Paul S, Delair T
(2017) Carbohydr Polym 172 :265-274
2016
180. First Membrane Proximal External Region-Specific Anti-HIV1 Broadly Neutralizing Monoclonal IgA1 Presenting Short CDRH3 and Low Somatic Mutations.
Benjelloun F, Oruc Z, Thielens N, Verrier B, Champier G, Vincent N, Rochereau N, Girard A, Jospin F, Chanut B, Genin C, Cogne M, Paul S
(2016) J Immunol 197 :1979-88
179. Poly(Lactic Acid) Nanoparticles Targeting ?5?1 Integrin as Vaccine Delivery Vehicle, a Prospective Study.
Dalzon B, Lebas C, Jimenez G, Gutjahr A, Terrat C, Exposito Jy, Verrier B, Lethias C
(2016) Plos One 11 :e0167663-e0167663
178. Synthesis and biological evaluation of thiophene and benzo[b]thiophene analogs of combretastatin A-4 and isocombretastatin A-4: A comparison between the linkage positions of the 3,4,5-trimethoxystyrene unit.
Do Cv, Faouzi A, Barette C, Farce A, Fauvarque Mo, Colomb E, Catry L, Berthier-vergnes O, Haftek M, Barret R, Lomberget T
(2016) Bioorg Med Chem Lett 26 :174-80
177. Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting.
Gutjahr A, Phelip C, Coolen Al, Monge C, Boisgard As, Paul S, Verrier B
(2016) Vaccines (basel) 4 :0
176. Controlled association and delivery of nanoparticles from jet-sprayed hybrid microfibrillar matrices.
Keloglu N, Verrier B, Trimaille T, Sohier J
(2016) Colloids Surf B Biointerfaces 140 :142-9
175. Evaluation of polylactic acid nanoparticles safety using Drosophila model.
Legaz S, Exposito Jy, Lethias C, Viginier B, Terzian C, Verrier B
(2016) Nanotoxicology 10 :1136-43
174. Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands.
Pavot V, Climent N, Rochereau N, Garcia F, Genin C, Tiraby G, Vernejoul F, Perouzel E, Lioux T, Verrier B, Paul S
(2016) Biomaterials 75 :327-339
173. Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity.
Rochereau N, Pavot V, Verrier B, Jospin F, Ensinas A, Genin C, Corthesy B, Paul S
(2016) J Allergy Clin Immunol 137 :214-222
172. Composite wound dressings of pectin and gelatin with aloe vera and curcumin as bioactive agents.
Tummalapalli M, Berthet M, Verrier B, Deopura Bl, Alam Ms, Gupta B
(2016) Int J Biol Macromol 82 :104-13
171. Drug loaded composite oxidized pectin and gelatin networks for accelerated wound healing.
Tummalapalli M, Berthet M, Verrier B, Deopura Bl, Alam Ms, Gupta B
(2016) Int J Pharm 505 :234-45
170. Zinc-Stabilized Chitosan-Chondroitin Sulfate Nanocomplexes for HIV-1 Infection Inhibition Application.
Wu D, Ensinas A, Verrier B, Primard C, Cuvillier A, Champier G, Paul S, Delair T
(2016) Mol Pharm 13 :3279-91
2015
169. A Novel Alpha Cardiac Actin (ACTC1) Mutation Mapping to a Domain in Close Contact with Myosin Heavy Chain Leads to a Variety of Congenital Heart Defects, Arrhythmia and Possibly Midline Defects.
Augiere C, Megy S, El Malti R, Boland A, El Zein L, Verrier B, Megarbane A, Deleuze Jf, Bouvagnet P
(2015) Plos One 10 :e0127903-e0127903
168. Myoconductive and osteoinductive free-standing polysaccharide membranes.
Caridade Sg, Monge C, Almodovar J, Guillot R, Lavaud J, Josserand V, Coll Jl, Mano Jf, Picart C
(2015) Acta Biomater 15 :139-49
167. Preparation and in vitro evaluation of imiquimod loaded polylactide-based micelles as potential vaccine adjuvants.
Jimenez-sanchez G, Pavot V, Chane-haong C, Handke N, Terrat C, Gigmes D, Trimaille T, Verrier B
(2015) Pharm Res 32 :311-20
166. A purified truncated form of yeast Gal4 expressed in Escherichia coli and used to functionalize poly(lactic acid) nanoparticle surface is transcriptionally active in cellulo.
Legaz S, Exposito Jy, Borel A, Candusso Mp, Megy S, Montserret R, Lahaye V, Terzian C, Verrier B
(2015) Protein Expr Purif 113 :94-101
165. Spatio-Temporal Control of LbL Films for Biomedical Applications: From 2D to 3D.
Monge C, Almodovar J, Boudou T, Picart C
(2015) Adv Healthc Mater 4 :811-30
164. Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells.
Rochereau N, Pavot V, Verrier B, Ensinas A, Genin C, Corthesy B, Paul S
(2015) Eur J Immunol 45 :773-9
163. New easy handling and sampling device for bioavailability screening of topical formulations.
Salmon D, Gilbert E, Gioia B, Haftek M, Pivot C, Verrier B, Pirot F
(2015) Eur J Dermatol 25 Suppl 1 :23-9
162. Micelle-Based Adjuvants for Subunit Vaccine Delivery.
Trimaille T, Verrier B
(2015) Vaccines (basel) 3 :803-13
161. Tenascin-X: beyond the architectural function.
Valcourt U, Alcaraz Lb, Exposito Jy, Lethias C, Bartholin L
(2015) Cell Adh Migr 9 :154-65
2014
160. Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β.
Alcaraz Lb, Exposito Jy, Chuvin N, Pommier Rm, Cluzel C, Martel S, Sentis S, Bartholin L, Lethias C, Valcourt U
(2014) J Cell Biol 205 :409-28
159. Spatial patterning of BMP-2 and BMP-7 on biopolymeric films and the guidance of muscle cell fate.
Almodovar J, Guillot R, Monge C, Vollaire J, Selimovi? S, Coll Jl, Khademhosseini A, Picart C
(2014) Biomaterials 35 :3975-85
158. Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.
Climent N, Munier S, Pique N, Garcia F, Pavot V, Primard C, Casanova V, Gatell Jm, Verrier B, Gallart T
(2014) Vaccine 32 :6266-76
157. Co-delivery of Antigen p24 and NOD-ligands by PLA Nanoparticles to Human Dendritic Cells Promote Highly Functional HIV-1-Specific T-cell Responses.
Climent N, Pavot V, Garcia F, Lioux T, Perouzel E, Primard C, Paul S, Gatell Jm, Plana M, Verrier B, Gallart T
(2014) Aids Res Hum Retroviruses 30 Suppl 1 :A240-1
156. Skin Migratory APCs Fine-tune Lymph Node Microenvironment for the Generation of T Follicular Helper Cells and Mucosal Immunity.
Levin C, Nuttens C, Bonduelle O, Perrin H, Verrier B, Fazilleau N, Combadiere B
(2014) Aids Res Hum Retroviruses 30 Suppl 1 :A126-7
155. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
Pavot V, Berthet M, Resseguier J, Legaz S, Handke N, Gilbert Sc, Paul S, Verrier B
(2014) Nanomedicine (lond) 9 :2703-18
154. Recent progress in HIV vaccines inducing mucosal immune responses.
Pavot V, Rochereau N, Lawrence P, Girard Mp, Genin C, Verrier B, Paul S
(2014) Aids 28 :1701-18
153. Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity.
Pavot V, Rochereau N, Resseguier J, Gutjahr A, Genin C, Tiraby G, Perouzel E, Lioux T, Vernejoul F, Verrier B, Paul S
(2014) J Immunol 193 :5781-5
152. Chimeric Nod2/TLR2 Ligand Amplifies HIV-1 Gag p24-specific Mucosal and Systemic Immune Responses after Sub Cutaneous Immunization in Mice.
Phelip C, Pavot V, Rochereau N, Perouzel E, Lioux T, Tiraby G, Primard C, Paul S, Verrier B
(2014) Aids Res Hum Retroviruses 30 Suppl 1 :A195-A195
151. [Application of gene therapy to oncologic ophthalmology].
Philiponnet A, Grange Jd, Baggetto Lg
(2014) J Fr Ophtalmol 37 :155-65
150. Particle-based transcutaneous administration of HIV-1 p24 protein to human skin explants and targeting of epidermal antigen presenting cells.
Rancan F, Amselgruber S, Hadam S, Munier S, Pavot V, Verrier B, Hackbarth S, Combadiere B, Blume-peytavi U, Vogt A
(2014) J Control Release 176 :115-22
149. Large-scale nucleotide optimization of simian immunodeficiency virus reduces its capacity to stimulate type I interferon in vitro.
Vabret N, Bailly-bechet M, Lepelley A, Najburg V, Schwartz O, Verrier B, Tangy F
(2014) J Virol 88 :4161-72
2013
148. Secretory IgA specific for MPER can protect from HIV-1 infection in vitro.
Benjelloun F, Dawood R, Urcuqui-inchima S, Rochereau N, Chanut B, Verrier B, Lucht F, Genin C, Paul S
(2013) Aids 27 :1992-5
147. Free-standing polyelectrolyte membranes made of chitosan and alginate.
Caridade Sg, Monge C, Gilde F, Boudou T, Mano Jf, Picart C
(2013) Biomacromolecules 14 :1653-60
146. Lysine-tagged peptide coupling onto polylactide nanoparticles coated with activated ester-based amphiphilic copolymer: a route to highly peptide-functionalized biodegradable carriers.
Handke N, Ficheux D, Rollet M, Delair T, Mabrouk K, Bertin D, Gigmes D, Verrier B, Trimaille T
(2013) Colloids Surf B Biointerfaces 103 :298-303
145. Elaboration of glycopolymer-functionalized micelles from an N-vinylpyrrolidone/lactide-based reactive copolymer platform.
Handke N, Lahaye V, Bertin D, Delair T, Verrier B, Gigmes D, Trimaille T
(2013) Macromol Biosci 13 :1213-20
144. Rigidity-patterned polyelectrolyte films to control myoblast cell adhesion and spatial organization.
Monge C, Saha N, Boudou T, Pozos-vasquez C, Dulong V, Glinel K, Picart C
(2013) Adv Funct Mater 23 :3432-3442
143. Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties.
Pavot V, Rochereau N, Primard C, Genin C, Perouzel E, Lioux T, Paul S, Verrier B
(2013) J Control Release 167 :60-7
142. Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.
Pollard C, Rejman J, De Haes W, Verrier B, Van Gulck E, Naessens T, De Smedt S, Bogaert P, Grooten J, Vanham G, De Koker S
(2013) Mol Ther 21 :251-9
141. Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells.
Rochereau N, Drocourt D, Perouzel E, Pavot V, Redelinghuys P, Brown Gd, Tiraby G, Roblin X, Verrier B, Genin C, Corthesy B, Paul S
(2013) Plos Biol 11 :e1001658-e1001658
140. Influence of polyelectrolyte film stiffness on bacterial growth.
Saha N, Monge C, Dulong V, Picart C, Glinel K
(2013) Biomacromolecules 14 :520-8
2012
139. Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies.
Benjelloun F, Lawrence P, Verrier B, Genin C, Paul S
(2012) J Virol 86 :13152-63
138. Cutting edge: Protective effect of CX3CR1+ dendritic cells in a vaccinia virus pulmonary infection model.
Bonduelle O, Duffy D, Verrier B, Combadiere C, Combadiere B
(2012) J Immunol 188 :952-6
137. Structural basis of fibrillar collagen trimerization and related genetic disorders.
Bourhis Jm, Mariano N, Zhao Y, Harlos K, Exposito Jy, Jones Ey, Moali C, Aghajari N, Hulmes Dj
(2012) Nat Struct Mol Biol 19 :1031-6
136. Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8+ T cells.
Duffy D, Perrin H, Abadie V, Benhabiles N, Boissonnas A, Liard C, Descours B, Reboulleau D, Bonduelle O, Verrier B, Van Rooijen N, Combadiere C, Combadiere B
(2012) Immunity 37 :917-29
135. Engineering muscle tissues on microstructured polyelectrolyte multilayer films.
Monge C, Ren K, Berton K, Guillot R, Peyrade D, Picart C
(2012) Tissue Eng Part A 18 :1664-76
134. New insights in mucosal vaccine development.
Pavot V, Rochereau N, Genin C, Verrier B, Paul S
(2012) Vaccine 30 :142-54
133. A synthetic peptide derived from the parasite Toxoplasma gondii triggers human dendritic cells' migration.
Persat F, Mercier C, Ficheux D, Colomb E, Trouillet S, Bendridi N, Musset K, Loeuillet C, Cesbron-delauw Mf, Vincent C
(2012) J Leukoc Biol 92 :1241-50
132. Stability of polylactic acid particles and release of fluorochromes upon topical application on human skin explants.
Rancan F, Todorova A, Hadam S, Papakostas D, Luciani E, Graf C, Gernert U, Ruhl E, Verrier B, Sterry W, Blume-peytavi U, Vogt A
(2012) Eur J Pharm Biopharm 80 :76-84
131. The biased nucleotide composition of HIV-1 triggers type I interferon response and correlates with subtype D increased pathogenicity.
Vabret N, Bailly-bechet M, Najburg V, Muller-trutwin M, Verrier B, Tangy F
(2012) Plos One 7 :e33502-e33502
130. Metabolic consequences of NDUFS4 gene deletion in immortalized mouse embryonic fibroblasts.
Valsecchi F, Monge C, Forkink M, De Groof Aj, Benard G, Rossignol R, Swarts Hg, Van Emst-de Vries Se, Rodenburg Rj, Calvaruso Ma, Nijtmans Lg, Heeman B, Roestenberg P, Wieringa B, Smeitink Ja, Koopman Wj, Willems Ph
(2012) Biochim Biophys Acta 1817 :1925-36
2011
129. Isolation, characterization and biological evaluation of jellyfish collagen for use in biomedical applications.
Addad S, Exposito Jy, Faye C, Ricard-blum S, Lethias C
(2011) Mar Drugs 9 :967-83
128. Elaboration of Densely Functionalized Polylactide Nanoparticles from N-Acryloxysuccinimide-Based Block Copolymers
Handke N, Trimaille T, Luciani E, Rollet M, Delair T, Verrier B, Bertin D, Gigmes D,
(2011) Journal Of Polymer Science Part A-polymer Chemistry 49 :1341-1350
127. Intradermal immunization triggers epidermal langerhans-cell mobilization required For CD8 T-cell immune responses
Liard C, Menier S, Joulin-giet A, Vogt A, Bonduelle O, Hadam S, Duffy D, Verrier B, Combadiere B
(2011) Journal Of Investigative Dermatology 131 :S101-S101
126. Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses.
Liard C, Munier S, Arias M, Joulin-giet A, Bonduelle O, Duffy D, Shattock Rj, Verrier B, Combadiere B
(2011) Vaccine 29 :6379-91
125. Poly(lactic acid) nanoparticles [Nps of PLA] as anti-tumoral vaccination vehicles
Munier S, Borel A, Gauthier Y, Delair T, Verrier B
(2011) Bulletin Du Cancer 98 :S68-S69
124. Biodegradable poly lactic acid particles for transcutaneous drug delivery and skin cell targeting
Rancan F, Amselgruber S, Hadam S, Munier S, Delair T, Verrier B, Sterry W, Blume-peytavi U, Vogt A
(2011) Experimental Dermatology 20 :208-209
123. Phenotypic localization of distinct DC subsets in mouse Peyer Patch.
Rochereau N, Verrier B, Pin Jj, Genin C, Paul S
(2011) Vaccine 29 :3655-61
122. Phenotypic localization of distinct DC subsets in mouse Peyer Patch
Rochereau N, Verrier B, Pin Jj, Genin C, Paul S
(2011) Vaccine 29 :3655-3661
2010
121. Capture of enveloped viruses using polymer tentacles containing magnetic latex particles.
Arkhis A, Elaissari A, Delair T, Verrier B, Mandrand B
(2010) J Biomed Nanotechnol 6 :28-36
120. The fibrillar collagen family.
Exposito Jy, Valcourt U, Cluzel C, Lethias C
(2010) Int J Mol Sci 11 :407-26
119. Study of possible interactions of tubulin, microtubular network, and STOP protein with mitochondria in muscle cells.
Guerrero K, Monge C, Bruckner A, Puurand U, Kadaja L, Kaambre T, Seppet E, Saks V
(2010) Mol Cell Biochem 337 :239-49
118. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.
Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B, De Lamballerie X, Suhrbier A, Cherel Y, Le Grand R, Roques P
(2010) J Clin Invest 120 :894-906
117. Tenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis.
Margaron Y, Bostan L, Exposito Jy, Malbouyres M, Trunfio-sfarghiu Am, Berthier Y, Lethias C
(2010) Biophys Chem 147 :87-91
116. Structure-function relationships in feedback regulation of energy fluxes in vivo in health and disease: mitochondrial interactosome.
Saks V, Guzun R, Timohhina N, Tepp K, Varikmaa M, Monge C, Beraud N, Kaambre T, Kuznetsov A, Kadaja L, Eimre M, Seppet E
(2010) Biochim Biophys Acta 1797 :678-97
115. Polylactic acid (PLA) particles for hair follicle targeting: controlled release of incorporated fluorochromes after skin contact
Todorova A, Rancan F, Luciani E, Graf C, Verrier B, Sterry W, Vogt A
(2010) Experimental Dermatology 19 :596-596
114. Polysaccharide-based vaccine delivery systems: Macromolecular assembly, interactions with antigen presenting cells, and in vivo immunomonitoring.
Weber C, Drogoz A, David L, Domard A, Charles Mh, Verrier B, Delair T
(2010) J Biomed Mater Res A 93 :1322-34
113. Co-adsorption of TLR3 ligand and HIV-1 antigens increase potency of particulate vaccine vehicles based on chitosan or poly (lactic acid) backbone
Weber C, Verrier B
(2010) Aids Research And Human Retroviruses 26 :A39-A39
2009
112. Original encounter with antigen determines antigen-presenting cell imprinting of the quality of the immune response in mice.
Abadie V, Bonduelle O, Duffy D, Parizot C, Verrier B, Combadiere B
(2009) Plos One 4 :e8159-e8159
111. Matrix and envelope coevolution revealed in a patient monitored since primary infection with human immunodeficiency virus type 1.
Beaumont E, Vendrame D, Verrier B, Roch E, Biron F, Barin F, Mammano F, Brand D
(2009) J Virol 83 :9875-89
110. Regulation of respiration controlled by mitochondrial creatine kinase in permeabilized cardiac cells in situ. Importance of system level properties.
Guzun R, Timohhina N, Tepp K, Monge C, Kaambre T, Sikk P, Kuznetsov Av, Pison C, Saks V
(2009) Biochim Biophys Acta 1787 :1089-105
109. Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice.
Mahe B, Vogt A, Liard C, Duffy D, Abadie V, Bonduelle O, Boissonnas A, Sterry W, Verrier B, Blume-peytavi U, Combadiere B
(2009) J Invest Dermatol 129 :1156-64
108. Comparative analysis of the bioenergetics of adult cardiomyocytes and nonbeating HL-1 cells: respiratory chain activities, glycolytic enzyme profiles, and metabolic fluxes.
Monge C, Beraud N, Tepp K, Pelloux S, Chahboun S, Kaambre T, Kadaja L, Roosimaa M, Piirsoo A, Tourneur Y, Kuznetsov Av, Saks V, Seppet E
(2009) Can J Physiol Pharmacol 87 :318-26
107. PLA-nanoparticles as a drug delivery system for topical dermatotherapy
Papakostas D, Rancan F, Hadam S, Hackbarth S, Delair T, Verrier B, Sterry W, Blume-peytavi U, Vogt A
(2009) Experimental Dermatology 18 :305-305
106. Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients.
Puissant-lubrano B, Combadiere B, Duffy D, Wincker N, Frachette Mj, Ait-mohand H, Verrier B, Katlama C, Autran B
(2009) Vaccine 27 :3576-83
105. Philosophical basis and some historical aspects of systems biology: from Hegel to Noble - applications for bioenergetic research.
Saks V, Monge C, Guzun R
(2009) Int J Mol Sci 10 :1161-92
104. Direct measurement of energy fluxes from mitochondria into cytoplasm in permeabilized cardiac cells in situ: some evidence for Mitochondrial Interactosome.
Timohhina N, Guzun R, Tepp K, Monge C, Varikmaa M, Vija H, Sikk P, Kaambre T, Sackett D, Saks V
(2009) J Bioenerg Biomembr 41 :259-75
2008
103. Regulation of brain endothelial cells migration and angiogenesis by P-glycoprotein/caveolin-1 interaction.
Barakat S, Turcotte S, Demeule M, Lachambre Mp, Regina A, Baggetto Lg, Beliveau R
(2008) Biochem Biophys Res Commun 372 :440-6
102. Towards biocompatible vaccine delivery systems: interactions of colloidal PECs based on polysaccharides with HIV-1 p24 antigen.
Drogoz A, Munier S, Verrier B, David L, Domard A, Delair T
(2008) Biomacromolecules 9 :583-91
101. Demosponge and sea anemone fibrillar collagen diversity reveals the early emergence of A/C clades and the maintenance of the modular structure of type V/XI collagens from sponge to human.
Exposito Jy, Larroux C, Cluzel C, Valcourt U, Lethias C, Degnan Bm
(2008) J Biol Chem 283 :28226-35
100. Regulation of respiration in brain mitochondria and synaptosomes: restrictions of ADP diffusion in situ, roles of tubulin, and mitochondrial creatine kinase.
Monge C, Beraud N, Kuznetsov Av, Rostovtseva T, Sackett D, Schlattner U, Vendelin M, Saks Va
(2008) Mol Cell Biochem 318 :147-65
99. Tubulin binding blocks mitochondrial voltage-dependent anion channel and regulates respiration.
Rostovtseva Tk, Sheldon Kl, Hassanzadeh E, Monge C, Saks V, Bezrukov Sm, Sackett Dl
(2008) Proc Natl Acad Sci U S A 105 :18746-51
2007
98. Generation of specific Th1 and CD8+ T-cell responses by immunization with mouse CD8+ dendritic cells loaded with HIV-1 viral lysate or envelope glycoproteins.
Aline F, Brand D, Bout D, Pierre J, Fouquenet D, Verrier B, Dimier-poisson I
(2007) Microbes Infect 9 :536-43
97. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route.
Cleret A, Quesnel-hellmann A, Vallon-eberhard A, Verrier B, Jung S, Vidal D, Mathieu J, Tournier Jn
(2007) J Immunol 178 :7994-8001
96. Survival after primary enucleation for choroidal melanoma: changes induced by the introduction of conservative therapies.
Gambrelle J, Grange Jd, Devouassoux Shisheboran M, Rivoire M, Baggetto Lg, Jean-louis B, Fleury J, Kodjikian L
(2007) Graefes Arch Clin Exp Ophthalmol 245 :657-63
95. Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits.
Guillon C, Mayol K, Terrat C, Compagnon C, Primard C, Charles Mh, Delair T, Munier S, Verrier B
(2007) Vaccine 25 :7491-501
94. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
Lambele M, Labrosse B, Roch E, Moreau A, Verrier B, Barin F, Roingeard P, Mammano F, Brand D
(2007) J Virol 81 :125-40
93. Characterization of the antibody response elicited by HIV-1 Env glycomutants in rabbits.
Reynard F, Willkomm N, Fatmi A, Vallon-eberhard A, Verrier B, Bedin F
(2007) Vaccine 25 :535-46
2006
92. Insights into early extracellular matrix evolution: spongin short chain collagen-related proteins are homologous to basement membrane type IV collagens and form a novel family widely distributed in invertebrates.
Aouacheria A, Geourjon C, Aghajari N, Navratil V, Deleage G, Lethias C, Exposito Jy
(2006) Mol Biol Evol 23 :2288-302
91. Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.
Ataman-onal Y, Munier S, Ganee A, Terrat C, Durand Py, Battail N, Martinon F, Le Grand R, Charles Mh, Delair T, Verrier B
(2006) J Control Release 112 :175-85
90. Replacement of HIV-1 Env natural cleavage sites by aphtovirus 2A peptides
Bedin F , Fatmi A , Reynard F , Vallon A , Durand Py , Verrier B
(2006) Journal Of Clinical Virology 36 :S51-S51
89. A model of tenascin-X integration within the collagenous network.
Lethias C, Carisey A, Comte J, Cluzel C, Exposito Jy
(2006) Febs Lett 580 :6281-5
88. Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.
Van Gulck Er, Ponsaerts P, Heyndrickx L, Vereecken K, Moerman F, De Roo A, Colebunders R, Van Den Bosch G, Van Bockstaele Dr, Van Tendeloo Vf, Allard S, Verrier B, Maranon C, Hoeffel G, Hosmalin A, Berneman Zn, Vanham G
(2006) Blood 107 :1818-27
2005
87. Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects.
Baggetto Lg, Gambrelle J, Dayan G, Labialle S, Barakat S, Michaud M, Grange Jd, Gayet L
(2005) Cancer Treat Rev 31 :361-79
86. Multidrug-resistant cancer cells contain two populations of P-glycoprotein with differently stimulated P-gp ATPase activities: evidence from atomic force microscopy and biochemical analysis.
Barakat S, Gayet L, Dayan G, Labialle S, Lazar A, Oleinikov V, Coleman Aw, Baggetto Lg
(2005) Biochem J 388 :563-71
85. Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope.
Cheynet V, Ruggieri A, Oriol G, Blond Jl, Boson B, Vachot L, Verrier B, Cosset Fl, Mallet F
(2005) J Virol 79 :5585-93
84. [Mechanisms of resistance to sexual transmission of HIV-1].
Eberhard A, Ponceau B, Biron F, Verrier B
(2005) Med Mal Infect 35 :517-24
83. Uveal melanoma in an 18-year-old African black man.
Gambrelle J, Dayan G, Baggetto Lg, Devouassoux-shisheboran M, Salle M, Labialle S, Gayet L, Barakat S, Kodjikian L, Grange Jd
(2005) Acta Ophthalmol Scand 83 :134-6
82. [Multidrug resistance in uveal melanoma].
Gambrelle J, Labialle S, Dayan G, Gayet L, Barakat S, Michaud M, Grange Jd, Baggetto Lg
(2005) J Fr Ophtalmol 28 :652-9
81. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
Gayet L, Dayan G, Barakat S, Labialle S, Michaud M, Cogne S, Mazane A, Coleman Aw, Rigal D, Baggetto Lg
(2005) Biochemistry 44 :4499-509
80. Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives.
Labialle S, Dayan G, Gambrelle J, Gayet L, Barakat S, Devouassoux-shisheboran M, Bernaud J, Rigal D, Grange Jd, Baggetto Lg
(2005) Melanoma Res 15 :257-66
79. Gene therapy of the typical multidrug resistance phenotype of cancers: a new hope?
Labialle S, Dayan G, Michaud M, Barakat S, Rigal D, Baggetto Lg
(2005) Semin Oncol 32 :583-90
78. Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties.
Munier S, Messai I, Delair T, Verrier B, Ataman-onal Y
(2005) Colloids Surf B Biointerfaces 43 :163-73
2004
77. Invertebrate data predict an early emergence of vertebrate fibrillar collagen clades and an anti-incest model.
Aouacheria A, Cluzel C, Lethias C, Gouy M, Garrone R, Exposito Jy
(2004) J Biol Chem 279 :47711-9
76. Distinct maturations of N-propeptide domains in fibrillar procollagen molecules involved in the formation of heterotypic fibrils in adult sea urchin collagenous tissues.
Cluzel C, Lethias C, Garrone R, Exposito Jy
(2004) J Biol Chem 279 :9811-7
75. Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope.
Dacheux L, Moreau A, Ataman-onal Y, Biron F, Verrier B, Barin F
(2004) J Virol 78 :12625-37
74. [Toward monosomy 3 as the main prognosis factor of uveal melanoma: current cytogenetic data].
Gambrelle J, Labialle S, Dayan G, Gayet L, Barakat S, Grange Jd, Baggetto Lg
(2004) J Fr Ophtalmol 27 :1061-7
73. New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein.
Labialle S, Dayan G, Gayet L, Rigal D, Gambrelle J, Baggetto Lg
(2004) Nucleic Acids Res 32 :3864-76
72. HIV-1 acute infection env glycomutants designed from 3D model: effects on processing, antigenicity, and neutralization sensitivity.
Reynard F, Fatmi A, Verrier B, Bedin F
(2004) Virology 324 :90-102
71. Short communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples.
Vachot L, Ataman-onal Y, Terrat C, Durand Py, Ponceau B, Biron F, Verrier B
(2004) Aids Res Hum Retroviruses 20 :687-91
2003
70. Elaboration of poly(ethyleneimine) coated poly(D,L-lactic acid) particles. Effect of ionic strength on the surface properties and DNA binding capabilities
Messai I, Munier S, Ataman-onal Y, Verrier B, Delair T
(2003) Colloids And Surfaces B-biointerfaces 32 :293-305
2002
69. Evolution of collagens.
Exposito Jy, Cluzel C, Garrone R, Lethias C
(2002) Anat Rec 268 :302-16
68. Transcriptional regulation of the human MDR1 gene at the level of the inverted MED-1 promoter region.
Labialle S, Gayet L, Marthinet E, Rigal D, Baggetto Lg
(2002) Ann N Y Acad Sci 973 :468-71
67. Transcriptional regulators of the human multidrug resistance 1 gene: recent views.
Labialle S, Gayet L, Marthinet E, Rigal D, Baggetto Lg
(2002) Biochem Pharmacol 64 :943-8
66. Evaluation in rhesus macaques of Tat and rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08.
Verrier B, Le Grand R, Ataman-onal Y, Terrat C, Guillon C, Durand Py, Hurtrel B, Aubertin Am, Sutter G, Erfle V, Girard M
(2002) Dna Cell Biol 21 :653-8
65. Effects of P-glycoprotein on the properties of lipid monolayers probed by Langmuir-Blodgett technique
Zaitsev Sy, Volchenkova Ta, Ustinova Oa, Koshtigo Tv, Baggetto Lg, Fleury F, Madoulet C, Nabiev Ir, Oleinikov Va
(2002) Biofizika 47 :1073-1079
2001
64. Characterization of fibrosurfin, an interfibrillar component of sea urchin catch connective tissues.
Cluzel C, Lethias C, Humbert F, Garrone R, Exposito Jy
(2001) J Biol Chem 276 :18108-14
63. Binding of tenascin-X to decorin.
Elefteriou F, Exposito Jy, Garrone R, Lethias C
(2001) Febs Lett 495 :44-7
62. Identification and characterization of a conformational heparin-binding site involving two fibronectin type III modules of bovine tenascin-X.
Lethias C, Elefteriou F, Parsiegla G, Exposito Jy, Garrone R
(2001) J Biol Chem 276 :16432-8
2000
61. Long-term safety and antiretroviral activity of hydroxyurea and didanosine in HIV-infected patients.
Biron F, Ponceau B, Bouhour D, Boibieux A, Verrier B, Peyramond D
(2000) J Acquir Immune Defic Syndr 25 :329-36
60. Sea urchin fibrillar collagen 2alpha chain participates in heterotrimeric molecules of (1alpha)(2)2alpha stoichiometry.
Cluzel C, Lethias C, Garrone R, Exposito Jy
(2000) Matrix Biol 19 :545-7
59. Production in mammalian cells of chimeric human/sea urchin procollagen molecules displaying distinct versions of the minor triple helix.
Cluzel C, Lethias C, Garrone R, Exposito Jy
(2000) J Biochem 128 :957-63
58. Tracing the evolution of vertebrate fibrillar collagens from an ancestral alpha chain.
Exposito J, Cluzel C, Lethias C, Garrone R
(2000) Matrix Biol 19 :275-9
57. Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter.
Marthinet E, Divita G, Bernaud J, Rigal D, Baggetto Lg
(2000) Gene Ther 7 :1224-33
56. Triple helix assembly and processing of human collagen produced in transgenic tobacco plants.
Ruggiero F, Exposito Jy, Bournat P, Gruber V, Perret S, Comte J, Olagnier B, Garrone R, Theisen M
(2000) Febs Lett 469 :132-6
55. Molecular adaptation to an extreme environment: origin of the thermal stability of the pompeii worm collagen.
Sicot Fx, Mesnage M, Masselot M, Exposito Jy, Garrone R, Deutsch J, Gaill F
(2000) J Mol Biol 302 :811-20
1999
54. Cell adhesion to tenascin-X mapping of cell adhesion sites and identification of integrin receptors.
Elefteriou F, Exposito Jy, Garrone R, Lethias C
(1999) Eur J Biochem 263 :840-8
53. Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization.
Fayolle J, Verrier B, Buckland R, Wild Tf
(1999) J Virol 73 :787-90
52. Generation of monoclonal antibodies to native human immunodeficiency virus type 1 envelope glycoprotein by immunization of mice with naked RNA.
Giraud A, Ataman-onal Y, Battail N, Piga N, Brand D, Mandrand B, Verrier B
(1999) J Virol Methods 79 :75-84
1998
51. Evolution of HIV antibody testing
Ataman-onal Y, Biron F, Verrier B
(1998) Medecine Et Maladies Infectieuses 28 :496-504
50. In vitro and in vivo reversal of cancer cell multidrug resistance by the semi-synthetic antibiotic tiamulin.
Baggetto Lg, Dong M, Bernaud J, Espinosa L, Rigal D, Bonvallet R, Marthinet E
(1998) Biochem Pharmacol 56 :1219-28
49. Secondary structure of P-glycoprotein investigated by circular dichroism and amino acid sequence analysis.
Dong M, Ladaviere L, Penin F, Deleage G, Baggetto Lg
(1998) Biochim Biophys Acta 1371 :317-34
48. Quantitative and discriminative detection of individual HIV-1 mRNA subspecies by an RNase mapping assay.
Mary C, Akaoka H, Verrier B
(1998) Methods Mol Biol 92 :89-100
1997
47. Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.
Baggetto Lg
(1997) J Bioenerg Biomembr 29 :401-13
46. Non P-glycoprotein novel proteins involved in human cancer multidrug resistance.
Baggetto Lg
(1997) Bull Cancer 84 :385-90
45. Transmission of the human immunodeficiency virus and the hepatitis C virus.
Biron F, Verrier B, Peyramond D
(1997) N Engl J Med 337 :348-9
44. [HTLV I virus infection disclosed by recurrent scabies associated with genital condylomatosis].
Dupin M, Guennoc B, Zimmermann R, Martin L, Verrier B, Flechaire A, Combemale P
(1997) Ann Med Interne (paris) 148 :406-7
43. Characterization of the bovine tenascin-X.
Elefteriou F, Exposito Jy, Garrone R, Lethias C
(1997) J Biol Chem 272 :22866-74
42. Collagen fibrillogenesis during sea urchin development--retention of SURF motifs from the N-propeptide of the 2alpha chain in mature fibrils.
Lethias C, Exposito Jy, Garrone R
(1997) Eur J Biochem 245 :434-40
41. Cloning of an annelid fibrillar-collagen gene and phylogenetic analysis of vertebrate and invertebrate collagens.
Sicot Fx, Exposito Jy, Masselot M, Garrone R, Deutsch J, Gaill F
(1997) Eur J Biochem 246 :50-8
40. Comparative analysis of fibrillar and basement membrane collagen expression in embryos of the sea urchin, Strongylocentrotus purpuratus.
Suzuki Hr, Reiter Rs, D'alessio M, Di Liberto M, Ramirez F, Exposito Jy, Gambino R, Solursh M
(1997) Zoolog Sci 14 :449-54
1996
39. Imbalanced expression of glutamate-glutamine cycle enzymes induced by human T-cell lymphotropic virus type 1 Tax protein in cultivated astrocytes.
Akaoka H, Hardin-pouzet H, Bernard A, Verrier B, Belin Mf, Giraudon P
(1996) J Virol 70 :8727-36
38. Type IV collagen in sponges, the missing link in basement membrane ubiquity.
Boute N, Exposito Jy, Boury-esnault N, Vacelet J, Noro N, Miyazaki K, Yoshizato K, Garrone R
(1996) Biol Cell 88 :37-44
37. At an early differentiation stage, the dendritic cells Langerhans cells are infectable by HIV-1 in an in vitro infection model
Charbonnier As, Dezutterdambuvant C, Fiers Mm, Jacquet C, Verrier B, Mallet F, Mandrand B, Schmitt D
(1996) Journal Of Investigative Dermatology 107 :P46-P46
36. In vitro HIV1 infection of CD34+ progenitor-derived dendritic/Langerhans cells at different stages of their differentiation in the presence of GM-CSF/TNF alpha.
Charbonnier As, Verrier B, Jacquet C, Massacrier C, Fiers Mm, Mallet F, Dezutter-dambuyant C, Schmitt D
(1996) Res Virol 147 :89-95
35. Efficient purification and reconstitution of P-glycoprotein for functional and structural studies.
Dong M, Penin F, Baggetto Lg
(1996) J Biol Chem 271 :28875-83
1995
34. IN-VITRO HIV-1 INFECTION OF CD34+ PRECURSORS OF DENDRITIC CELLS LANGERHANS CELLS AT THE EARLY DIFFERENTIATION
Charbonnier As, Verrier B, Jacquet C, Massacrier C, Fiers Mm, Mallet F, Dezutterdambuyant C, Schmitt D
(1995) Journal Of Investigative Dermatology 105 :499-499
33. Characterization of two genes coding for a similar four-cysteine motif of the amino-terminal propeptide of a sea urchin fibrillar collagen.
Exposito Jy, Boute N, Deleage G, Garrone R
(1995) Eur J Biochem 234 :59-65
32. Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of metalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I.
Giraudon P, Thomasset N, Bernard A, Verrier B, Belin Mf
(1995) Eur J Neurosci 7 :841-8
31. Cell surface phenotypic changes induced in H9 T cells chronically infected with HTLV type I or HIV type 1 or coinfected with the two viruses.
Noraz N, Verrier B, Fraisier C, Desgranges C
(1995) Aids Res Hum Retroviruses 11 :145-54
1994
30. Transient adult T-cell leukemia/lymphoma picture during varicella infection in an HTLV-1 carrier.
D'incan M, Combemale P, Verrier B, Garin D, Audoly G, Brunot J, Desgranges C, Flechaire A
(1994) Leukemia 8 :682-7
29. Identification of a cell lineage-specific gene coding for a sea urchin alpha 2(IV)-like collagen chain.
Exposito Jy, Suzuki H, Geourjon C, Garrone R, Solursh M, Ramirez F
(1994) J Biol Chem 269 :13167-71
28. Quantitative and discriminative detection of individual HIV-1 mRNA subspecies by an RNAse mapping assay.
Mary C, Telles Jn, Cheynet V, Oriol G, Mallet F, Mandrand B, Verrier B
(1994) J Virol Methods 49 :9-23
1993
27. Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification.
Cheynet V, Verrier B, Mallet F
(1993) Protein Expr Purif 4 :367-72
26. CLINICAL AND BIOLOGICAL FEATURES OF PRIMARY HIV-INFECTION - REVIEW OF PUBLISHED LITERATURE
Denoray G, Biron F, Verrier B, Boibieux A, Bailly Ma, Bertrand Jl, Peyramond D
(1993) Medecine Et Maladies Infectieuses 23 :643-652
25. Complete primary structure of a sea urchin type IV collagen alpha chain and analysis of the 5' end of its gene.
Exposito Jy, D'alessio M, Di Liberto M, Ramirez F
(1993) J Biol Chem 268 :5249-54
24. The complete intron/exon structure of Ephydatia mulleri fibrillar collagen gene suggests a mechanism for the evolution of an ancestral gene module.
Exposito Jy, Van Der Rest M, Garrone R
(1993) J Mol Evol 37 :254-9
23. [Phylogenesis of the extracellular matrix].
Garrone R, Exposito Jy, Franc Jm, Franc S, Humbert-david N, Qin L, Tillet E
(1993) C R Seances Soc Biol Fil 187 :114-23
22. DETECTION OF MULTIPLY-SPLICED MESSENGER-RNAS AND REGULATORY PROTEINS DURING HIV-INFECTION
Gruters Ra, Mary C, Cheynet V, Oriol G, Mallet F, Verrier B
(1993) Journal Of Cellular Biochemistry Suppl. 17E :47-47
1992
21. Role of mitochondria in carcinogenesis.
Baggetto Lg
(1992) Eur J Cancer 29A :156-9
20. Low mitochondrial proton leak due to high membrane cholesterol content and cytosolic creatine kinase as two features of the deviant bioenergetics of Ehrlich and AS30-D tumor cells.
Baggetto Lg, Clottes E, Vial C
(1992) Cancer Res 52 :4935-41
19. Inhibition of CD25 (IL-2R alpha) expression and T-cell proliferation by polyclonal anti-thymocyte globulins.
Bonnefoy-berard N, Verrier B, Vincent C, Revillard Jp
(1992) Immunology 77 :61-7
18. Monocyte-independent T-cell activation by polyclonal antithymocyte globulins.
Bonnefoy-berard N, Vincent C, Verrier B, Revillard Jp
(1992) Cell Immunol 143 :272-83
17. Novel amino-terminal propeptide configuration in a fibrillar procollagen undergoing alternative splicing.
Exposito Jy, D'alessio M, Ramirez F
(1992) J Biol Chem 267 :17404-8
16. Sea urchin collagen evolutionarily homologous to vertebrate pro-alpha 2(I) collagen.
Exposito Jy, D'alessio M, Solursh M, Ramirez F
(1992) J Biol Chem 267 :15559-62
15. THE COLLAGEN FAMILY OF PROTEINS - 2 DISTINCT LINES OF EVOLUTION
Garrone R, Exposito Jy
(1992) Belgian Journal Of Zoology 122 :17-22
1991
14. Four regulatory elements in the human c-fos promoter mediate transactivation by HTLV-1 Tax protein.
Alexandre C, Verrier B
(1991) Oncogene 6 :543-51
13. RESEARCH OF HTLV1-LIKE RETROVIRAL SEQUENCES IN PSORIASIS
Bernard F, Bassetseguin N, Verrier B, Mion H, Guilhou Jj
(1991) Journal Of Investigative Dermatology 96 :640-640
12. Identification of F0 subunits in the rat liver mitochondrial F0F1-ATP synthase.
Cretin F, Baggetto Lg, Denoroy L, Godinot C
(1991) Biochim Biophys Acta 1058 :141-6
11. Short chain collagens in sponges are encoded by a family of closely related genes.
Exposito Jy, Le Guellec D, Lu Q, Garrone R
(1991) J Biol Chem 266 :21923-8
10. Retrovirus-mediated gene transfer of a human c-fos cDNA into mouse bone marrow stromal cells.
Roux P, Verrier B, Klein B, Niccolino M, Marty L, Alexandre C, Piechaczyk M
(1991) Oncogene 6 :2155-60
1990
9. Role of acetoin on the regulation of intermediate metabolism of Ehrlich ascites tumor mitochondria: its contribution to membrane cholesterol enrichment modifying passive proton permeability.
Baggetto Lg, Testa-parussini R
(1990) Arch Biochem Biophys 283 :241-8
8. Characterization of a fibrillar collagen gene in sponges reveals the early evolutionary appearance of two collagen gene families.
Exposito Jy, Garrone R
(1990) Proc Natl Acad Sci U S A 87 :6669-73
7. Cloning and sequencing of a Porifera partial cDNA coding for a short-chain collagen.
Exposito Jy, Ouazana R, Garrone R
(1990) Eur J Biochem 190 :401-6
6. A MINIATURE COLLAGEN DISCOVERED IN SPONGES BY CDNA CLONING
Exposito Jy, Vincent P, Garrone R
(1990) Annals Of The New York Academy Of Sciences 580 :444-447
1987
5. Formation and utilization of acetoin, an unusual product of pyruvate metabolism by Ehrlich and AS30-D tumor mitochondria.
Baggetto Lg, Lehninger Al
(1987) J Biol Chem 262 :9535-41
4. Isolated tumoral pyruvate dehydrogenase can synthesize acetoin which inhibits pyruvate oxidation as well as other aldehydes.
Baggetto Lg, Lehninger Al
(1987) Biochem Biophys Res Commun 145 :153-9
1986
3. Reversal of glucose-induced inhibition of newborn rat liver mitochondrial maturation by administration of alkylxanthines at birth.
Comte J, Meister R, Baggetto Lg, Godinot C, Gautheron Dc
(1986) Biochem Pharmacol 35 :2411-6
1984
2. Effects of ATP on various steps controlling the rate of oxidative phosphorylation in newborn rat liver mitochondria.
Baggetto L, Gautheron Dc, Godinot C
(1984) Arch Biochem Biophys 232 :670-8
1983
1. High phosphate requirement for oxidative phosphorylation and low affinity for phosphate transport in newborn rat liver mitochondria.
Baggetto L, Comte J, Meister R, Godinot C
(1983) Biochimie 65 :685-90
